| Hematology - Hematopoietic stem cells take advantage of 'junk' RNA to replenish the blood system |
|
|
|
|
| |
|
| |
The latest hematology news from News Medical |
|
|
|
 | | |
 Top cell therapy targets for hematological malignancies
Till April 2021, according to the data published on ClinicalTrials.gov, there are 1,358 active cell therapy trials, among which most trials are focusing on hematological malignancies. Typical targets include CD19, BCMA, and CD22.
ACROBiosystems offers a series of CAR-T target proteins for hematological tumor research, such as CD19, BCMA, CD20, and CD30 products, which are suitable for detecting CAR expression in clinical trials.
| |
|
|
| | | | |  Ever since the association between cancer and thrombosis was reported by Jean-Baptiste Bouillaud in the early 19th century, cancer-associated thrombosis has remained a challenging domain of cancer management. | | | | |  Leukemia is a group of blood cancers that affects thousands of people worldwide. However, with advances in medicine, several different types of leukemia can be effectively treated with donor stem cells through allogenic stem cell transplantation (allo-SCT). | | | | |  Dr. Elizabeta Nemeth, professor of medicine and director of the Center for Iron Disorders at the David Geffen School of Medicine at UCLA, has been awarded the 2021 William Dameshek Prize by the American Society of Hematology (ASH) for her contributions to the field of hematology. | | | | |  Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. New research published in the Journal of Leukocyte Biology reveals that certain protein markers may indicate which patients have stable forms of CLL and which have more aggressive types. | |
|
|
|
|
|
|
|
